The traditional approach of most anti-doping organizations places considerable (but not exclusive) emphasis on Adverse Analytical Findings (under Articles 7.23-7.27 of the CADP). This direct approach is reliant on the identification of new prohibited substances, and the development of analytical methods to detect them. An indirect approach, such as the ABP program, while still subject to the same scientific rigour, would reduce the urgency for new analytical tests, allow for doping to be detected while these new tests are being developed, and increase the deterrent effect of testing.